Alpine Global Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$145K | – | 510 |
|
|
2022
Q3 | $145K | Hold |
10,000
| – | – | 0.03% | 119 |
|
|
2022
Q2 | $98K | Hold |
10,000
| – | – | 0.02% | 149 |
|
|
2022
Q1 | $147 | Hold |
10,000
| – | – | 0.03% | 268 |
|
|
2021
Q4 | $132K | Sell |
10,000
-2,754
| -22% | -$36.4K | 0.02% | 539 |
|
|
2021
Q3 | $223K | Buy |
+12,754
| New | +$223K | 0.05% | 196 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$257K | – | 338 |
|
|
2021
Q1 | $257K | Buy |
+10,000
| New | +$257K | 0.02% | 220 |
|